Interactive role of breast cancer on dyslipidemia and hypertension metabolic risk according to treatment exposure and menopausal status

Breast cancer (BC) is the principal cause of cancer related deaths among women worldwide. The available evidence suggests that cardio-metabolic risk factors such as dyslipidemia and hypertension may contribute differently to breast cancer severity and pathogenesis. The aim of this study is to evalua...

Full description

Saved in:
Bibliographic Details
Main Authors: Al-Zeidaneen Safaa A., Ahmad Mousa N., Al-Ebous Ali D., Saudi Rawan MohD Al
Format: Article
Language:English
Published: Sciendo 2021-05-01
Series:Forum of Clinical Oncology
Subjects:
Online Access:https://doi.org/10.2478/fco-2019-0018
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849225020877832192
author Al-Zeidaneen Safaa A.
Ahmad Mousa N.
Al-Ebous Ali D.
Saudi Rawan MohD Al
author_facet Al-Zeidaneen Safaa A.
Ahmad Mousa N.
Al-Ebous Ali D.
Saudi Rawan MohD Al
author_sort Al-Zeidaneen Safaa A.
collection DOAJ
description Breast cancer (BC) is the principal cause of cancer related deaths among women worldwide. The available evidence suggests that cardio-metabolic risk factors such as dyslipidemia and hypertension may contribute differently to breast cancer severity and pathogenesis. The aim of this study is to evaluate the interactive role of BC on dyslipidemia and HTN risk according to the type of treatment exposure and menopausal status.
format Article
id doaj-art-4ce4a151253f4f418d62d4e7b25de221
institution Kabale University
issn 1792-362X
language English
publishDate 2021-05-01
publisher Sciendo
record_format Article
series Forum of Clinical Oncology
spelling doaj-art-4ce4a151253f4f418d62d4e7b25de2212025-08-25T06:11:53ZengSciendoForum of Clinical Oncology1792-362X2021-05-01121394610.2478/fco-2019-0018Interactive role of breast cancer on dyslipidemia and hypertension metabolic risk according to treatment exposure and menopausal statusAl-Zeidaneen Safaa A.0Ahmad Mousa N.1Al-Ebous Ali D.2Saudi Rawan MohD Al3Department of Allied Medical Sciences, Al-Zarqa University College, Al-Balqa Applied University, Al-Salt, JordanDepartment of Nutrition and Food Technology, Faculty of Agriculture, the University of Jordan, Amman, JordanBreast Cancer Unite, Department of General Surgery, King Hussein Medical Center, Amman, JordanDepartment of Allied Medical Sciences, Al-Zarqa University College, Al-Balqa Applied University, Al-Salt, JordanBreast cancer (BC) is the principal cause of cancer related deaths among women worldwide. The available evidence suggests that cardio-metabolic risk factors such as dyslipidemia and hypertension may contribute differently to breast cancer severity and pathogenesis. The aim of this study is to evaluate the interactive role of BC on dyslipidemia and HTN risk according to the type of treatment exposure and menopausal status.https://doi.org/10.2478/fco-2019-0018breast cancerchemotherapyhypertensionlipid profile
spellingShingle Al-Zeidaneen Safaa A.
Ahmad Mousa N.
Al-Ebous Ali D.
Saudi Rawan MohD Al
Interactive role of breast cancer on dyslipidemia and hypertension metabolic risk according to treatment exposure and menopausal status
Forum of Clinical Oncology
breast cancer
chemotherapy
hypertension
lipid profile
title Interactive role of breast cancer on dyslipidemia and hypertension metabolic risk according to treatment exposure and menopausal status
title_full Interactive role of breast cancer on dyslipidemia and hypertension metabolic risk according to treatment exposure and menopausal status
title_fullStr Interactive role of breast cancer on dyslipidemia and hypertension metabolic risk according to treatment exposure and menopausal status
title_full_unstemmed Interactive role of breast cancer on dyslipidemia and hypertension metabolic risk according to treatment exposure and menopausal status
title_short Interactive role of breast cancer on dyslipidemia and hypertension metabolic risk according to treatment exposure and menopausal status
title_sort interactive role of breast cancer on dyslipidemia and hypertension metabolic risk according to treatment exposure and menopausal status
topic breast cancer
chemotherapy
hypertension
lipid profile
url https://doi.org/10.2478/fco-2019-0018
work_keys_str_mv AT alzeidaneensafaaa interactiveroleofbreastcancerondyslipidemiaandhypertensionmetabolicriskaccordingtotreatmentexposureandmenopausalstatus
AT ahmadmousan interactiveroleofbreastcancerondyslipidemiaandhypertensionmetabolicriskaccordingtotreatmentexposureandmenopausalstatus
AT alebousalid interactiveroleofbreastcancerondyslipidemiaandhypertensionmetabolicriskaccordingtotreatmentexposureandmenopausalstatus
AT saudirawanmohdal interactiveroleofbreastcancerondyslipidemiaandhypertensionmetabolicriskaccordingtotreatmentexposureandmenopausalstatus